Amendements — recherche transverse
284 amendements trouvés. La recherche full-text porte sur le dispositif et l'exposé sommaire.
| Texte | n° | Article | Auteur | Examen | Sort | Date |
|---|---|---|---|---|---|---|
| DLR5L17N51255 | 37 | ARTICLE PREMIER | Elie Califer SOC | commission | Discuté | 2026-05-06 |
| DLR5L17N51987 | 201 | ARTICLE UNIQUE | Elie Califer SOC | commission | Discuté | 2026-04-09 |
| DLR5L17N51987 | 200 | ARTICLE UNIQUE | Elie Califer SOC | commission | Discuté | 2026-04-09 |
| DLR5L17N51987 | 199 | ARTICLE UNIQUE | Elie Califer SOC | commission | Discuté | 2026-04-09 |
| DLR5L17N51987 | 198 | ARTICLE UNIQUE | Elie Califer SOC | commission | En traitement | 2026-04-09 |
| DLR5L17N51987 | 197 | ARTICLE UNIQUE | Elie Califer SOC | commission | Irrecevable | 2026-04-09 |
| DLR5L17N51987 | 196 | ARTICLE UNIQUE | Elie Califer SOC | commission | Discuté | 2026-04-09 |
| DLR5L17N51987 | 195 | ARTICLE UNIQUE | Elie Califer SOC | commission | Discuté | 2026-04-09 |
| DLR5L17N51987 | 194 | ARTICLE UNIQUE | Elie Califer SOC | commission | Discuté | 2026-04-09 |
| DLR5L17N51987 | 193 | ARTICLE UNIQUE | Elie Califer SOC | commission | Discuté | 2026-04-09 |
| DLR5L17N51987 | 192 | ARTICLE UNIQUE | Elie Califer SOC | commission | Irrecevable | 2026-04-09 |
| DLR5L17N51987 | 191 | ARTICLE UNIQUE | Elie Califer SOC | commission | Retiré | 2026-04-09 |
| DLR5L17N51987 | 190 | ARTICLE UNIQUE | Elie Califer SOC | commission | Irrecevable | 2026-04-09 |
| DLR5L17N51987 | 189 | ARTICLE UNIQUE | Elie Califer SOC | commission | Discuté | 2026-04-09 |
| DLR5L17N51987 | 188 | ARTICLE UNIQUE | Elie Califer SOC | commission | Discuté | 2026-04-09 |
| DLR5L17N51987 | 187 | ARTICLE UNIQUE | Elie Califer SOC | commission | Irrecevable | 2026-04-09 |
| DLR5L17N51987 | 186 | ARTICLE UNIQUE | Elie Califer SOC | commission | Irrecevable | 2026-04-09 |
| DLR5L17N51987 | 185 | ARTICLE UNIQUE | Elie Califer SOC | commission | Discuté | 2026-04-09 |
| DLR5L17N51987 | 184 | ARTICLE UNIQUE | Elie Califer SOC | commission | Discuté | 2026-04-09 |
| DLR5L17N51987 | 183 | ARTICLE UNIQUE | Elie Califer SOC | commission | Discuté | 2026-04-09 |
| DLR5L17N51987 | 182 | APRÈS L'ARTICLE UNIQUE | Elie Califer SOC | commission | Discuté | 2026-04-09 |
| DLR5L17N51987 | 181 | APRÈS L'ARTICLE UNIQUE | Elie Califer SOC | commission | Discuté | 2026-04-09 |
| DLR5L17N51987 | 180 | ARTICLE UNIQUE | Elie Califer SOC | commission | Irrecevable | 2026-04-09 |
| DLR5L17N51987 | 179 | ARTICLE UNIQUE | Elie Califer SOC | commission | Irrecevable | 2026-04-09 |
| DLR5L17N53774 | 2 | ARTICLE PREMIER | Elie Califer SOC | commission | Discuté | 2026-04-03 |
| DLR5L17N53774 | 1 | ARTICLE PREMIER | Elie Califer SOC | commission | Discuté | 2026-04-03 |
| DLR5L17N53426 | 14 | ARTICLE 2 | Elie Califer SOC | commission | Adopté | 2026-04-02 |
| DLR5L17N53426 | 2 | ARTICLE 2 | Elie Califer SOC | commission | Rejeté | 2026-04-02 |
| DLR5L17N53426 | 1 | ARTICLE 2 | Elie Califer SOC | commission | Rejeté | 2026-04-02 |
| DLR5L17N53426 | — | ARTICLE PREMIER | Elie Califer SOC | seance | Tombé | 2026-03-25 |
| DLR5L17N53426 | — | ARTICLE PREMIER | Elie Califer SOC | seance | Tombé | 2026-03-25 |
| DLR5L17N53426 | — | APRÈS L'ARTICLE 2, insérer l'article suivant: | Elie Califer SOC | seance | Retiré | 2026-03-25 |
| DLR5L17N53426 | — | ARTICLE PREMIER | Elie Califer SOC | seance | Tombé | 2026-03-25 |
| DLR5L17N53426 | — | ARTICLE 2 | Elie Califer SOC | seance | Tombé | 2026-03-25 |
| DLR5L17N52428 | 2833 | ARTICLE 79 BIS | Elie Califer SOC | seance | En traitement | 2026-01-10 |
| DLR5L17N52428 | 2445 | ARTICLE 49 | Elie Califer SOC | seance | En traitement | 2026-01-10 |
| DLR5L17N52428 | — | ARTICLE 49 | Elie Califer SOC | seance | Adopté | 2026-01-06 |
| DLR5L17N52428 | — | ARTICLE 79 BIS | Elie Califer SOC | seance | Adopté | 2026-01-05 |
| DLR5L17N52428 | — | ARTICLE 49 | Elie Califer SOC | seance | En traitement | 2025-11-20 |
| DLR5L17N52428 | — | ARTICLE 49 | Elie Califer SOC | seance | En traitement | 2025-11-20 |
| DLR5L17N52428 | — | ARTICLE 49 | Elie Califer SOC | seance | En traitement | 2025-11-14 |
| DLR5L17N52428 | — | ARTICLE 49 | Elie Califer SOC | seance | En traitement | 2025-11-14 |
| DLR5L17N52428 | — | ARTICLE 49 | Elie Califer SOC | seance | En traitement | 2025-11-14 |
| DLR5L17N52428 | — | ARTICLE 49 | Elie Califer SOC | seance | En traitement | 2025-11-14 |
| DLR5L17N52428 | — | ARTICLE 49 | Elie Califer SOC | seance | En traitement | 2025-11-14 |
| DLR5L17N52428 | — | ARTICLE 49 | Elie Califer SOC | seance | En traitement | 2025-11-13 |
| DLR5L17N52428 | — | ARTICLE 49 | Elie Califer SOC | seance | En traitement | 2025-11-13 |
| DLR5L17N52428 | — | ARTICLE 49 | Elie Califer SOC | seance | En traitement | 2025-11-13 |
| DLR5L17N52428 | — | ARTICLE 49 | Elie Califer SOC | seance | En traitement | 2025-11-13 |
| DLR5L17N52428 | — | ARTICLE 49 | Elie Califer SOC | seance | En traitement | 2025-11-13 |